Por favor, inténtelo con una nueva búsqueda
Símbolo | Mercado | Moneda | ||
---|---|---|---|---|
CVAC | NASDAQ | USD | Tiempo real | |
1CVAC | Milán | EUR | Tiempo real | |
5CV | Xetra | EUR | Demorada | |
5CV | TradeGate | EUR | Demorada | |
5CV | Fráncfort | EUR | Demorada | |
CVAC | Viena | EUR | Tiempo real |
CureVac NV es una empresa de biotecnología con sede en Alemania. La empresa se dedica al desarrollo terapéutico de ácido ribonucleico mensajero (ARNm) y vacunas basadas en ARN. CureVac AG se centra en el desarrollo de vacunas para enfermedades infecciosas y medicamentos para tratar el cáncer y enfermedades poco comunes. La cartera de productos de la empresa se centra en tres áreas: inmunoterapia contra el cáncer, vacunas profilácticas y terapias basadas en proteínas.
Nombre | Edad | Desde | Título |
---|---|---|---|
Baron Jean Stephenne | 72 | 2015 | Independent Chairman of Supervisory Board |
Michel De Wilde | 73 | 2016 | Member of Scientific Advisory Board |
Hans-Georg Rammensee | - | 2001 | Scientific Director of Immunology and Member of Scientific Advisory Board |
Jean-Paul Prieels | - | 2016 | Member of Scientific Advisory Board |
Christopher Karp | - | 2016 | Member of Scientific Advisory Board |
Stanley A. Plotkin | 91 | 2016 | Member of Scientific Advisory Board |
Fred Zepp | - | 2016 | Member of Scientific Advisory Board |
Nina Bhardwaj | - | 2016 | Member of Scientific Advisory Board |
Mathias P. Hothum | 57 | 2015 | Supervisory Board Member |
Michael P. Manns | - | 2016 | Member of Scientific Advisory Board |
Craig A. Tooman | 58 | 2019 | Supervisory Board Member |
Daniel Speiser | - | 2016 | Member of Scientific Advisory Board |
Xiao-Ning Xu | - | 2016 | Member of Scientific Advisory Board |
George R. Siber | 79 | 2016 | Member of Scientific Advisory Board |
Dirk Jäger | - | 2016 | Member of Scientific Advisory Board |
Klaus Schollmeier | 67 | 2022 | Supervisory Board Member |
Karim Fizazi | 58 | 2016 | Member of Scientific Advisory Board |
Gerd Zettlmeissl | 69 | 2016 | Member of Scientific Advisory Board |
Viola Bronsema | 60 | 2020 | Supervisory Board Member |
Debra Barker | 62 | 2022 | Supervisory Board Member |
Michael Brosnan | 69 | 2023 | Independent Director of Supervisory Board |
Craig L. Slingluff | - | 2023 | Member of Scientific Advisory Board |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores